首页> 美国卫生研究院文献>Journal of Laparoendoscopic Advanced Surgical Techniques. Part A >Recurrence of Hepatocellular Carcinoma After Laparoscopic Hepatectomy: Risk Factors and Treatment Strategies
【2h】

Recurrence of Hepatocellular Carcinoma After Laparoscopic Hepatectomy: Risk Factors and Treatment Strategies

机译:腹腔镜肝切除术后肝细胞癌复发:危险因素及治疗策略

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Purpose: To investigate the risk factors for recurrence and treatment strategies after patients with hepatocellular carcinoma (HCC) undergo total laparoscopic hepatectomy (LH).>Methods: The study included 109 patients who underwent LH (laparoscopy resection [LR] group, n = 50) or open hepatectomy [OH] (open resection [OR] group, n = 59) for HCC in our hospital between March 2011 and June 2016. Perioperative outcomes, disease recurrence, survival, and risk factors for recurrence were analyzed.>Results: Patient characteristics did not significantly differ between groups. The 1- and 3-year survival rates were 90.7% and 78.1%, respectively, for the LR group and 83.1% and 74.4%, respectively, for the OR group (P = .71). The 1- and 3-year disease-free survival rates were 89.6% and 51.4%, respectively, for the LR group and 84.7% and 59.6%, respectively, for the OR group (P = .935). Tumor size, differentiation, vascular invasion, surgical bleeding, and surgical resection margin were risk factors for tumor recurrence after LH.>Conclusion: LH for HCC did not increase the risk of recurrence compared with OH. Tumor size, differentiation, vascular invasion, surgical bleeding, and surgical resection margin were risk factors for tumor recurrence. Reducing bleeding during surgery and ensuring sufficient surgical margins were the most important measures to reduce postoperative recurrence of HCC.
机译:>目的:调查肝细胞癌(HCC)患者接受全腹腔镜肝切除术(LH)后复发的危险因素和治疗策略。>方法:该研究纳入了109例在2011年3月至2016年6月间,我院接受了LH(腹腔镜切除术[LR]组,n = 50)或开放式肝切除术[OH](开放切除术[OR]组,n = 59)。围手术期结局,疾病复发, >结果:两组之间的患者特征没有显着差异。 LR组的1年和3年生存率分别为90.7%和78.1%,OR组的分别为83.1%和74.4%(P = .71)。 LR组的1年和3年无病生存率分别为LR组和OR组的1年和3年无病生存率分别为89.6%和51.4%(P = .935)。肿瘤大小,分化,血管浸润,手术出血和手术切除余量是LH术后肿瘤复发的危险因素。>结论:与OH相比,LH治疗HCC并没有增加复发风险。肿瘤大小,分化,血管浸润,手术出血和手术切除切缘是肿瘤复发的危险因素。减少手术中的出血并确保足够的手术余量是减少HCC术后复发的最重要措施。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号